Eagan, MN, April 24, 2017 -- SelectAccount, a leader in health spending administration and one of the largest HSA non-bank custodians, announced today that Greg Champlain has joined the company as the Senior Vice President of National Account Sales. In his role, Greg will be responsible for National Account Sales and providing sales leadership within the Central Region, reporting to Chief Growth Officer E. Craig Keohan.
|
|||
Greg brings more than 10 years of health savings account and consumer driven health sales experience to SelectAccount. Most recently, Greg served as the Vice President of Sales at ConnectYourCare where he was responsible for business development in the Midwest. Prior to ConnectYourCare, Greg was a Regional Sales Director at HealthEquity. While at HealthEquity, he was named the top sales leader among his peers, selling hundreds of thousands health savings accounts during his tenure.
“We are very excited to welcome Greg to SelectAccount,” said E. Craig Keohan, SelectAccount Chief Growth Officer. “With HSAs being more popular than ever, we are looking forward to leveraging Greg’s tenured industry experience as we continue to expand our member base across the United States. I believe Greg’s passion for our business paired with his drive for success will help enable us to achieve our goals.”
To learn more about SelectAccount, visit SelectAccount.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7bfd06ea-b79e-4c70-bd22-730b225d472a
Linda Novitt SelectAccount 651.662.9176 [email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



